Biologics: Advanced Drugs that Deserve an Advanced Delivery Technology
November 20, 2017
Compared to conventional pharmaceutical drugs, biologics feature robust therapeutic efficacy, high selectivity, and limited side effects. However, there are marked limitations for the delivery of biologic drugs.
Planning Your Feasibility Study in Three Easy Steps
November 15, 2017
Portal’s Needle-Free Drug Delivery System is now available for clinical testing, human factor evaluation, and commercial planning.
The End of Needles: A Personal Win for Patients
November 9, 2017
Patients with chronic conditions who must receive frequent, sometimes even daily, injections are all too familiar with the sting and the inherent anxiety of handling needles. Portal’s innovative needle-free platform is changing the paradigm of care.
Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device
November 7, 2017
Portal Instruments and Takeda announced a collaboration to develop and commercialize Portal’s game changing needle-free drug delivery platform for potential use with Takeda’s investigational or approved biologic medicines.
A Letter From the CEO
November 7, 2017
Today we announced a groundbreaking partnership with Takeda. This is a significant milestone for Portal as it begins to validate our business model. I am thrilled about this achievement and would like to thank the whole team that has worked tirelessly to make this happen.
Boston Voyager Interviews Portal Instruments’ CEO Patrick Anquetil
August 25, 2017
Patrick Anquetil, CEO of Portal Instruments, was recently featured in Boston Voyager, an online magazine that focuses on local trends, start-ups and local businesses.
Portal Instruments Wins MedTech Breakthrough 2017 Award
August 25, 2017
Portal Instruments was awarded the MedTech Breakthrough 2017 Award for Best Overall Medical Device Product.
Portal Instruments’ CEO Patrick Anquetil interviewed by Medgadget
July 11, 2017
Portal Instruments’ CEO Patrick Anquetil was recently interviewed by Medgadget about Portal’s innovative needle-free drug delivery technology and its potential impact on existing treatment options of multiple chronic conditions.
Portal Instruments Appoints Wendy Dwyer as Chief Business Officer
July 11, 2017
Dwyer brings more than 18 years of business development experience to Portal Instruments. “Wendy is a proven leader with deep industry knowledge in forging strategic partnerships and a track record of getting things done and delivering results,” said Patrick Anquetil, CEO of Portal Instruments.
Drug Development and Delivery Showcases Portals’ Needle-Free Delivery Platform
June 8, 2017
Drug Development and Delivery recently published an article showcasing Portal Instruments’ transformative needle-free drug delivery platform and its partnership strategy.